1. FDA grants priority review to Roche's lung cancer drug Tecentriq — Teva drug fails in pediatric Tourette syndrome trial — GSK pays $50M for two solid tumor cell therapies from Immatics — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

VNUS Technologies

Anonymous board for VNUS Technologies


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    17
    Views:
    19,204
  2. Anonymous
    Replies:
    0
    Views:
    4,020
  3. Anonymous
    Replies:
    0
    Views:
    3,480

Thread Display Options

Loading...